UnderStand UPSCUPSC Live · 60 words

Social Justice & Health – UPSC Current Affairs

0/0 today
Social GS-II Must read

NMC warns students against admission in unauthorised medical colleges

The National Medical Commission (NMC) has cautioned students, parents and the public against taking admission in medical colleges without first verifying their statutory recognition and approval. In an advisory dated 5 November 2026, it said it had found institutions offering medical and allied health courses without permission from competent authorities.

19
Social GS-II Must read

Centre tells Supreme Court it may set up a committee to re-examine UGC’s 2026 equity regulations

On 5 November, Solicitor General Tushar Mehta told a Supreme Court bench of Chief Justice Surya Kant and Justice Joymalya Bagchi that the Government is contemplating a committee to re-examine the University Grants Commission's 2026 equity regulations. The Court adjourned the matter for four weeks.

19
Social GS-II Must read

Lenders propose institutional home loans for PMAY-G beneficiaries at MoRD-NHB Reform Samvad

At the "PMAY-G Reform Samvad" organised by the Ministry of Rural Development and the National Housing Bank (NHB) in Lonavala, lenders proposed dedicated rural housing loans of ₹2-5 lakh for Pradhan Mantri Awaas Yojana-Gramin beneficiaries, with repayment aligned to seasonal incomes. The ministry released the outcome on 2 November.

68
Social GS-II

NPPA notifies revised MRPs for 543 brands of anti-cancer drugs, effective 9 November

The National Pharmaceutical Pricing Authority (NPPA) on 28 October released revised maximum retail prices for 543 brands of anti-cancer drugs, which will take effect from 9 November 2026. The sample list shows price cuts of roughly 57% to 90%, such as denosumab falling from about ₹22,031 to ₹5,941 and bevacizumab from about ₹21,768 to ₹5,930 per vial.

43
Social GS-II Must read

NPPA caps trade margins on 137 cancer drugs at 30%

NPPA has capped trade margins on 137 non-scheduled anti-cancer drugs at 30% of MRP, effective November 9. It used its powers under Para 19 of DPCO 2013. Immunotherapies like pembrolizumab and nivolumab are covered, and so are patented drugs unless exempted. Mark-ups averaged about 170%, crossing 700% in some cases. The move extends a 2019 pilot on 42 drugs and will show whether margin caps can cut out-of-pocket cancer costs.

24

Stay informed in 60 words.

UPSC aspirants are short on time. So we bring the most important news from PIB, The Hindu and The Indian Express – live, subject-wise, in 60 words.